Ticker Scorecard - ZNTL Basics Company: Zentalis Pharmaceuticals, Inc. IPO Date: April 3, 2020 Sector: Healthcare Industry: Biotech Market Cap: $165.34M Activated in VL: True Average Daily Range Avg Daily Range: $0.97 | 3.39% Avg Daily Range (30 D): $0.13 | 5.52% Avg Daily Range (90 D): $0.13 | 4.47% Institutional Daily Volume Avg Daily Volume: .59M Avg Daily Volume (30 D): 2.32M Avg Daily Volume (90 D): 1.53M Trade Size Avg Trade Size (Sh.): 81 Avg Trade Size (Sh.) (30 D): 177 Avg Trade Size (Sh.) (90 D): 148 Institutional Trades Total Inst.Trades: 1,902 Avg Inst. Trade: $2.1M Avg Inst. Trade (30 D): $.84M Avg Inst. Trade (90 D): $1.03M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.75M Avg Closing Trade (30 D): $.53M Avg Closing Trade (90 D): $.98M Avg Closing Volume: 114.16K     News Feb 3, 2025 @ 10:42 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Jan 9, 2025 @ 12:00 PM Zentalis Pharmaceuticals Announces Azenosertib Fas... Source: N/A Jan 2, 2025 @ 9:53 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Nov 1, 2024 @ 11:04 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: N/A Sep 16, 2024 @ 11:00 AM Zentalis Pharmaceuticals Announces FDA Has Lifted ... Source: N/A Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.56 $-1.24 $.14 Diluted EPS $-.56 $-1.24 $.14 Revenue $ M $ M $ 40.56M Gross Profit $ $ $ Net Income / Loss $ -40.16M $ -88.28M $ 10.04M Operating Income / Loss $ -51.43M $ -65.15M $ -24.77M Cost of Revenue $ $ $ Net Cash Flow $ 4.29M $ -.64M $ 9.58M PE Ratio